Bluejay Diagnostics (BJDX) Interest & Investment Income (2024 - 2026)
Bluejay Diagnostics (BJDX) reported Interest & Investment Income of $18859.0 for Q1 2026, up 5.94% on a YoY basis from $17801.0 in Q1 2025, and down 40.21% sequentially from $31543.0 in Q4 2025.
Bluejay Diagnostics (BJDX) Interest & Investment Income (2024 - 2026) Analysis & Trends
Bluejay Diagnostics (BJDX) has 3 years of Interest & Investment Income data on file, last reported at $18859.0 in Q1 2026.
- For the quarter ending Q1 2026, Interest & Investment Income rose 5.94% year-over-year to $18859.0; the trailing twelve-month figure through Mar 2026 stood at $98617.0 (down 26.15% YoY), and the FY2025 full-year result was $97559.0, down 33.1% from the prior year.
- Interest & Investment Income eased to $18859.0 in Q1 2026, from $31543.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $61692.0 in Q3 2024 to a low of $15408.0 in Q2 2024.
- A 3-year average of $29137.9 and a median of $29254.0 in 2025 frame the typical range for Interest & Investment Income.
- Peak annual rise in Interest & Investment Income reached 89.86% in 2025, while the deepest fall reached 69.27% in 2025.
- Tracing BJDX's Interest & Investment Income over 3 years: stood at $38632.0 in 2024, then fell by 18.35% to $31543.0 in 2025, then tumbled by 40.21% to $18859.0 in 2026.
- Business Quant data shows BJDX's Interest & Investment Income at $18859.0 in Q1 2026, $31543.0 in Q4 2025, and $18961.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 106.00 Mn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 33.50 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 40.98 Mn |
| 10 | Bluejay Diagnostics | 1.07 Mn | 1.07 Mn | - | 18,859.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18,859.00 |
| Dec 31, 2025 | 31,543.00 |
| Sep 30, 2025 | 18,961.00 |
| Jun 30, 2025 | 29,254.00 |
| Mar 31, 2025 | 17,801.00 |
| Dec 31, 2024 | 38,632.00 |
| Sep 30, 2024 | 61,692.00 |
| Jun 30, 2024 | 15,408.00 |
| Mar 31, 2024 | 30,091.00 |